Drug Facts
Composition & Profile
Identifiers & Packaging
PRINCIPAL DISPLAY PANEL - 50 Pouch Case Label Anticoagulant Citrate Dextrose Solution, Solution A USP ACD-A 50 mL 50 x 50 mL Catalog # AMSACD-A Anticoagulant intended for use only with devices that prepare Platelet Rich Plasma (PRP) products for extracorporeal use. See Operator's Manuals for additional information and complete usage instructions. Sterile. Non-pyrogenic. Do not use unless the solution is clear and the container is intact and undamaged. Rx only. Single use container. Caution: Not for preparation of blood products for transfusion or for direct intravenous infusion. Storage Conditions: Room temperature (68° to 77°F, 20° to 25°C) Avoid excessive heat. Protect from freezing. Protect from direct sunlight. Each 10mL contains: Citric Acid Monohydrate USP 0.08 g Sodium Citrate Dihydrate USP 0.220 g Dextrose Monohydrate USP 0.245 g In Water for Injection USP Manufactured for Arteriocyte Medical Systems, Inc. 45 South Street, Hopkinton, MA., 01748 by Ivex Pharmaceuticals, Larne, BT40 2SH, UK. ARTERIOCYTE CELLULAR THERAPIES MEDICAL SYSTEMS Lot Expiry Date PRINCIPAL DISPLAY PANEL - 50 Pouch Case Label
- PRINCIPAL DISPLAY PANEL - 50 Pouch Case Label Anticoagulant Citrate Dextrose Solution, Solution A USP ACD-A 50 mL 50 x 50 mL Catalog # AMSACD-A Anticoagulant intended for use only with devices that prepare Platelet Rich Plasma (PRP) products for extracorporeal use. See Operator's Manuals for additional information and complete usage instructions. Sterile. Non-pyrogenic. Do not use unless the solution is clear and the container is intact and undamaged. Rx only. Single use container. Caution: Not for preparation of blood products for transfusion or for direct intravenous infusion. Storage Conditions: Room temperature (68° to 77°F, 20° to 25°C) Avoid excessive heat. Protect from freezing. Protect from direct sunlight. Each 10mL contains: Citric Acid Monohydrate USP 0.08 g Sodium Citrate Dihydrate USP 0.220 g Dextrose Monohydrate USP 0.245 g In Water for Injection USP Manufactured for Arteriocyte Medical Systems, Inc. 45 South Street, Hopkinton, MA., 01748 by Ivex Pharmaceuticals, Larne, BT40 2SH, UK. ARTERIOCYTE CELLULAR THERAPIES MEDICAL SYSTEMS Lot Expiry Date PRINCIPAL DISPLAY PANEL - 50 Pouch Case Label
Overview
Each 10mL contains Citric Acid Monohydrate USP 0.08 g Sodium Citrate Dihydrate USP 0.220 g Dextrose Monohydrate USP 0.245 g In Water for Injection USP
Dosage & Administration
Not available
Warnings & Precautions
No warnings available yet.
Storage & Handling
Recommended storage Room temperature (68° to 77°F, 20° to 25°C) Avoid excessive heat. Protect from freezing.